Xylem Inc. (NYSE:XYL) Receives $152.77 Consensus Target Price from Analysts

Shares of Xylem Inc. (NYSE:XYL) have received a consensus recommendation of “Moderate Buy” from the thirteen analysts that are covering the firm, MarketBeat reports. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $152.7692.

XYL has been the subject of several recent research reports. Weiss Ratings cut Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. Barclays cut their price target on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. Citigroup cut their price target on Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. UBS Group increased their price target on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Finally, Oppenheimer cut their price target on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a report on Wednesday, April 29th.

Xylem Trading Up 1.8%

XYL stock opened at $110.30 on Friday. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13. Xylem has a 12-month low of $105.29 and a 12-month high of $154.27. The stock has a market cap of $26.22 billion, a price-to-earnings ratio of 27.44, a PEG ratio of 1.54 and a beta of 1.04. The business’s 50-day moving average is $117.60 and its 200 day moving average is $129.31.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The business had revenue of $2.13 billion for the quarter, compared to analysts’ expectations of $2.11 billion. During the same period in the previous year, the firm posted $1.03 EPS. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, sell-side analysts anticipate that Xylem will post 5.51 EPS for the current fiscal year.

Xylem Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th will be given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Thursday, May 28th. Xylem’s payout ratio is presently 42.79%.

Xylem announced that its board has approved a stock buyback plan on Wednesday, February 25th that permits the company to buyback $1.50 billion in outstanding shares. This buyback authorization permits the industrial products company to reacquire up to 4.8% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s board believes its shares are undervalued.

Insider Activity at Xylem

In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. The trade was a 54.22% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jerome A. Peribere purchased 1,210 shares of Xylem stock in a transaction dated Monday, May 4th. The shares were purchased at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the transaction, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.32% of the stock is currently owned by insiders.

Institutional Trading of Xylem

Several institutional investors have recently made changes to their positions in XYL. Allen Capital Group LLC raised its stake in shares of Xylem by 13.2% in the 1st quarter. Allen Capital Group LLC now owns 6,300 shares of the industrial products company’s stock valued at $753,000 after acquiring an additional 734 shares during the period. Segall Bryant & Hamill LLC purchased a new stake in Xylem in the first quarter valued at approximately $231,000. Western Wealth Management LLC purchased a new stake in Xylem in the first quarter valued at approximately $88,000. Edgestream Partners L.P. raised its position in Xylem by 118.3% in the first quarter. Edgestream Partners L.P. now owns 60,778 shares of the industrial products company’s stock valued at $7,263,000 after purchasing an additional 32,940 shares during the period. Finally, Altshuler Shaham Ltd purchased a new stake in Xylem in the first quarter valued at approximately $49,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.